Juan Jin (金娟)1,2*, Tao-jie Zhou3*, Gui-ling Ren4*, Liang Cai1, Xiao-ming Meng1#. Novel insights into NOD-[like] receptors in renal diseases. Acta Pharmacol Sin. In press. （IF：6.15/中科院一区）
Wang F*, Wang JN*, He XY*, Suo XG, Li C, Ni WJ, Cai YT, He Y, Fang XY, Dong YH, Xing T, Yang YR, Zhang F, Zhong X, Zang HM, Liu MM, Li J, Meng XM#, Juan Jin (金娟)#. Stratifin promotes renal dysfunction in ischemic and nephrotoxic AKI mouse models via enhancing RIPK3-mediated necroptosis. Acta Pharmacol Sin. 2021 Apr 8. doi: 10.1038/s41401-021-00649-w. （IF：6.15/中科院一区）
Liu XQ*, Juan Jin(金娟)*, Li Z*, Jiang L, Dong YH, Cai YT, Wu MF, Wang JN, Ma TT, Wen JG, Liu MM, Li J, Wu YG, Meng XM#. Rutaecarpine Derivative Cpd-6c Alleviates Acute Kidney Injury by Targeting PDF4B, a Key Enzyme Mediating inflammation in Cisplatin Nephropathy. Biochemical Pharmacology, 2020 July 2:114132. （IF：5.858/中科院一区）
Gao L*, Zhong X*, Juan Jin(金娟)*, Li J, Meng XM#. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression. Signal Transduct Target Ther. 2020 Feb 14.5:9 （IF：18.187/中科院一区）
Xiaoming Meng*#, Juan Jin (金娟)*, Hui Yao Lan#. The driving role of macrophages in transition from acute kidney injury to chronic kidney disease.CHINESE MEDICAL JOURNAL. 2022.In press.
Hao-Lu Sun*,Yi-Wan Wu*, He-Ge Bian, Hui Yang, Heng Wang, Xiao-Ming Meng#, Juan Jin#. Function of uric acid transporters and their inhibitors in hyperuricaemia. Front Pharmacol. 2021 Jul 14;12:667753.
Qixia Liu*, Xiaohui Chen*, Min Kan, Jing Yang, Qian Gong, Rui Jin, Yulong Dai, Juan Jin#, Hongmei Zang#. Gypenoside XLIX loaded nanoparticles targeting therapy for renal fibrosis and its mechanism. Eur J Pharmacol,2021 Nov 5;910:174501. (共同通讯作者）
Xiaoxiao Liu*, Juan Jin*, Yajing Liu, Zhenguo Shen, Rongquan Zhao, Linlin Ou,Tian Xing#. Targeting TSP-1 decreased periodontitis by attenuating extracellular matrix degradation and alveolar bone destruction. Int Immunopharmacol,2021 Jul;96:107618.
Juan Jin*, Haolu Sun*, Chao Shi*, Hui Yang, Yiwan Wu, Wanhai Li, Yu-hang Dong, Liang Cai, Xiao-ming Meng#. Circular RNA in renal diseases. J Cell Mol Med. 2020 Jun;24(12):6523-6533.
Liu XQ*, Juan Jin*, Li Z*, Jiang L, Dong YH, Cai YT, Wu MF, Wang JN, Ma TT, Wen JG, Liu MM, Li J, Wu YG, Meng XM#. Rutaecarpine Derivative Cpd-6c Alleviates Acute Kidney Injury by Targeting PDF4B, a Key Enzyme Mediating inflammation in Cisplatin Nephropathy. Biochemical Pharmacology, 2020 July 2:114132.
Yang H, Wang M, Sun H, Zhu S, Juan Jin*. Synergetic Effect of EP1 Receptor Antagonist and (-)-Epigallocatechin-3-gallate in Hepatocellular Carcinom. Pharmacology. 2019;104(5-6):267-275.
Juan Jin, Yan Chang, Wei Wei*, Yi-fu He, Shan-shan Hu, Di Wang, Yu-jing Wu. Prostanoid EP1 receptor as a novel target of (-)-Epigallocatechin-3-gallate against hepatocellular carcinoma. Acta Pharmacologica Sinica, 2012:33(5): 701-9.
Juan Jin, Yan Chang, Wei Wei*. Clinical application and evaluation of anti-TNF-alpha agents for the treatment of rheumatoid arthritis. Acta Pharmacologica Sinica (2010) 31: 1133-1140.
Yi-Fu He#, Juan Jin#, Wei Wei*, Yan Chang, Bing Hu, Chu-Shu Ji, Wei-Dong Jia, Xiao-Qiu Wang, Ke Chen, Jian Chen. Overexpressed cyclooxygenase-2 in the noncancerous liver increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis (co-author). Canadian Journal of Gastroenterology, 2010; 24: 435-40.
